100 related articles for article (PubMed ID: 11824446)
1. In vitro fertilisation: many unknowns.
Prescrire Int; 2001 Dec; 10(56):187-8. PubMed ID: 11824446
[TBL] [Abstract][Full Text] [Related]
2. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
[TBL] [Abstract][Full Text] [Related]
3. Low-dose aspirin for prophylaxis of ovarian hyperstimulation syndrome.
Várnagy A; Koppan M; Manfai Z; Busznyak C; Bodis J
Fertil Steril; 2008 Apr; 89(4):1035-6. PubMed ID: 18353319
[No Abstract] [Full Text] [Related]
4. [Clinical outcome of patients with follicular development retardation by prolonged duration of gonadotropin administration for in vitro fertilization].
Chen SL; Sun L; Kong LH; Li L; Li J; Zhu L; Gao TM; Xing FQ
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):526-9. PubMed ID: 17983490
[TBL] [Abstract][Full Text] [Related]
5. [Some aspects of ovarian hyperstimulation syndrome].
Kovachev E; Kozovski I; Markova V; Andronov M; Cherneva S; Aleksandrov K
Akush Ginekol (Sofiia); 2003; 42(6):37-41. PubMed ID: 15067814
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization.
Shapiro BS; Daneshmand ST; Garner FC; Aguirre M; Thomas S
Fertil Steril; 2008 Jul; 90(1):231-3. PubMed ID: 17981269
[TBL] [Abstract][Full Text] [Related]
7. [Multiple pregnancies: epidemiology and management].
Braat DD; Schönbeck Y; Kremer JA
Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1952-5. PubMed ID: 14574778
[TBL] [Abstract][Full Text] [Related]
8. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
Zhu YM; Gao HJ; He RH; Huang HF
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
[TBL] [Abstract][Full Text] [Related]
9. [Minimal ovarian stimulation: certainly less dangerous but rarely as efficient].
Antoine JM; Verstraete L
Gynecol Obstet Fertil; 2006 Apr; 34(4):356-7. PubMed ID: 16564729
[No Abstract] [Full Text] [Related]
10. Prevention of ovarian hyperstimulation syndrome.
Wiwanitkit V
Fertil Steril; 2011 Jun; 95(8):e65; author reply e66. PubMed ID: 21530962
[No Abstract] [Full Text] [Related]
11. Obesity does not adversely affect results in patients who are undergoing in vitro fertilization and embryo transfer.
Dechaud H; Anahory T; Reyftmann L; Loup V; Hamamah S; Hedon B
Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):88-93. PubMed ID: 16417960
[TBL] [Abstract][Full Text] [Related]
12. Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome.
Spitzer D; Wogatzky J; Murtinger M; Zech MH; Haidbauer R; Zech NH
Fertil Steril; 2011 Jun; 95(8):2742-4.e1. PubMed ID: 21411081
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects of excessive ovarian response on the pregnancy rate of in vitro fertilization treatment.
Ng EH
Gynecol Endocrinol; 2009 Jan; 25(1):2-7. PubMed ID: 19165656
[No Abstract] [Full Text] [Related]
14. A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome.
Heijnen EM; Eijkemans MJ; Hughes EG; Laven JS; Macklon NS; Fauser BC
Hum Reprod Update; 2006; 12(1):13-21. PubMed ID: 16123051
[TBL] [Abstract][Full Text] [Related]
15. Two cases of cholestasis in the first trimester of pregnancy after ovarian hyperstimulation.
Zamah AM; El-Sayed YY; Milki AA
Fertil Steril; 2008 Oct; 90(4):1202.e7-10. PubMed ID: 18929050
[TBL] [Abstract][Full Text] [Related]
16. [Intrauterine insemination: spontaneous or medically-assisted ovulation?].
Massin N; Cédrin-Durnerin I; Hugues JN
Gynecol Obstet Fertil; 2004 Oct; 32(10):898-903. PubMed ID: 15501170
[TBL] [Abstract][Full Text] [Related]
17. [Pituitary down-regulation and ovulation stimulation with gradually increased gonadotropin in controlled ovarian hyperstimulation].
Zhu L; Song YL; Cui YG; Xing FQ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):361-3. PubMed ID: 17425993
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial.
Baker VL; Fujimoto VY; Kettel LM; Adamson GD; Hoehler F; Jones CE; Soules MR
Fertil Steril; 2009 Apr; 91(4):1005-11. PubMed ID: 18367182
[TBL] [Abstract][Full Text] [Related]
19. Follicular aspiration during the selection phase prevents severe ovarian hyperstimulation in patients with polycystic ovary syndrome who are undergoing in vitro fertilization.
Zhu WJ; Li XM; Chen XM; Zhang L
Eur J Obstet Gynecol Reprod Biol; 2005 Sep; 122(1):79-84. PubMed ID: 16154042
[TBL] [Abstract][Full Text] [Related]
20. [Gonadotrophin dose and ovarian response: relations to the clinical outcome of in vitro fertilization and embryo transfer].
Xiong XS; Chen SL; Sun L; Yin MN; Zhao EY; Song J
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):712-4. PubMed ID: 18504186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
